Tom
If you have a look at Solbec's Development Strategy, they are targeting both Mesothelioma & Melanoma (both relatively low-incidence cancers) in achieving Orphan Drug approval.
It was very interesting to see Progen has achieved OD approval only 3 months after commencing Phase 11 trials......
SBP
solbec pharmaceuticals limited
TomIf you have a look at Solbec's Development Strategy, they are...
Add to My Watchlist
What is My Watchlist?